Eric Hryhorenko

USPTO Granted Patents = 36 (Patent Applications = 7)

CIPO Patents = 13 (Patent Applications = 3)

EPO Patents = 24 (Patent Applications = 30)

Average Co-Inventor Count = 7.4

ph-index = 14

Forward Citations = 250(Granted Patents)

Company Filing History:

35 out of 2,076

Janssen Pharmaceutica Nv

patents

4 out of 170

Ortho-clinical Diagnostics, Inc

patents

1 out of 28

Saladax Biomedical Inc.

patents

where one patent can have more than one assignee

Years Active: 2015-2022

Loading Chart...

36 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11385246 - Antibodies to paliperidone and use thereof (2022-07-12),

2. 11226345 - Antibodies to olanzapine haptens and use thereof (2022-01-18),

3. 11225527 - Antibodies to paliperidone haptens and use thereof (2022-01-18),

4. 11105793 - Antibodies to aripiprazole haptens and use thereof (2021-08-31),

5. 11104742 - Antibodies to quetiapine and use thereof (2021-08-31),

6. 11046786 - Antibodies to olanzapine and use thereof (2021-06-29),

7. 10852313 - Antibodies to risperidone and use thereof (2020-12-01),

8. 10816561 - Antibodies to aripiprazole and use thereof (2020-10-27),

9. 10793644 - Antibodies to risperidone haptens and use thereof (2020-10-06),

10. 10712353 - Antibodies to olanzapine haptens and use thereof (2020-07-14),

11. 10690686 - Antibodies to risperidone and use thereof (2020-06-23),

12. 10488401 - Antibodies to aripiprazole haptens and use thereof (2019-11-26),

13. 10465013 - Antibodies to quetiapine haptens and use thereof (2019-11-05),

14. 10444250 - Antibodies to risperidone and use thereof (2019-10-15),

15. 10435478 - Antibodies to quetiapine and use thereof (2019-10-08),

Title: Eric Hryhorenko: A Pioneering Inventor in Immunoassay Technology

Introduction

Eric Hryhorenko, based in Hilton, NY, is a distinguished inventor known for his significant contributions to the field of immunoassay technology. With an impressive portfolio of 36 patents, Hryhorenko has developed innovative solutions that enhance the detection of pharmaceuticals in clinical settings.

Latest Patents

Among his latest inventions are two notable patents related to antibodies that bind to paliperidone. The first patent focuses on an antibody that can detect paliperidone in various sample types, particularly through a competitive immunoassay method. This advancement allows for point-of-care detection using a lateral flow assay device, which can simultaneously identify other medications such as aripiprazole, quetiapine, olanzapine, and risperidone. The second patent also concerns antibodies to paliperidone haptens, reinforcing the utility of his innovations in multiplex detection capabilities.

Career Highlights

Eric Hryhorenko has had an impactful career with prominent companies in the pharmaceutical and diagnostics sectors. He has worked at Janssen Pharmaceutica and Ortho-Clinical Diagnostics, where his research and inventions have contributed significantly to advancements in medical diagnostics and treatment monitoring.

Collaborations

Throughout his career, Eric has collaborated with notable colleagues such as Banumathi Sankaran and Thomas R. DeCory. These collaborations have played a vital role in the successful development and patenting of groundbreaking technologies within the immunoassay domain.

Conclusion

Eric Hryhorenko’s work exemplifies innovation in pharmaceutical detection methods, with his patents paving the way for more effective and rapid diagnosable tests. His contributions to the field underline the importance of research and development in healthcare and the potential for future breakthroughs.

This text is generated by artificial intelligence and may not be accurate.